MTOR and Cerebral ischemia: Besides, research underscores schaftoside’s neuroprotective capacity against cerebral ischemia/reperfusion injury (CI/RI), both in vitro and in vivo, by modulating the autophagy-mediated AMPK/mTOR pathway (Zhang L. et al., 2022).